Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlobeImmune Inc (NASDAQ:GBIM)

1.96
Delayed Data
As of 4:00pm ET
 +0.0269 / +1.39%
Today’s Change
0.72
Today|||52-Week Range
9.39
-49.35%
Year-to-Date
No recent news for GlobeImmune Inc.

Today’s Trading

Previous close1.93
Today’s open2.00
Day’s range1.93 - 2.04
Volume31,841
Average volume (3 months)138,369
Market cap$11.1M
Dividend yield--
Data as of 4:00pm ET, 05/02/2016

Growth & Valuation

Earnings growth (last year)+94.03%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+8.24%
P/E ratioNM
Price/Sales3.45
Price/Book3.72

Competitors

 Today’s
change
Today’s
% change
APPYVenaxis Inc-0.15-4.85%
GBSNGreat Basin Scientif...-0.19-6.17%
GALTUGalectin Therapeutic...0.000.00%
APHBAmpliPhi Biosciences...+0.05+1.68%
Data as of 4:00pm ET, 05/02/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$6.5M
Annual profit (last year)-$2.8M
Net profit margin-42.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Timothy C. Rodell
Secretary, Treasurer &
Vice President-Finance
C. Jeffrey Dekker
Corporate headquarters
Louisville, Colorado

Forecasts

Partner Offers

Search for Jobs